Trials / Completed
CompletedNCT03495674
Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome
CYCling Lynch Patients for Exercise and Prevention: CYCLE-P
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- M.D. Anderson Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies how well cycling works in preventing colorectal cancer in participants with Lynch syndrome. Exercise such as cycling may reduce colorectal cancer risk in participants with Lynch syndrome.
Detailed description
PRIMARY OBJECTIVES: I. To assess the feasibility of a 12-month exercise cycling intervention among Lynch syndrome (LS) patients. SECONDARY OBJECTIVES: I. To assess the effect size of exercise on circulating biomarkers as well as regulation of genomic, transcriptomic, and immunologic biomarkers in normal intestinal mucosa of LS patients. OUTLINE: Participants are assigned to 1 of 2 groups. GROUP I: Starting on day 15, participants wear FITBIT and complete cycling classes over 45 minutes 3 times a week for a total of 12 classes a month for up to 1 year. GROUP II: Starting on day 15, participants receive information about exercise guidelines and wear FITBIT to track heart rate and activities for up to 1 year. After completion of study interventions, participants are followed up at 30 days.
Conditions
- High-Frequency Microsatellite Instability
- Mismatch Repair Gene Mutation
- Mutation-Negative Lynch Syndrome
- Mutation-Positive Lynch Syndrome
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Exercise Intervention | Complete cycling classes |
| OTHER | Informational Intervention | Receive information about exercise guidelines |
| DEVICE | Monitoring Device | Wear Fitbit |
| OTHER | Questionnaire Administration | Complete questionnaire |
Timeline
- Start date
- 2018-04-04
- Primary completion
- 2024-01-02
- Completion
- 2024-01-02
- First posted
- 2018-04-12
- Last updated
- 2024-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03495674. Inclusion in this directory is not an endorsement.